Search

Session information—May 15, 2025

Topic'Optimizing vaccination strategies for chemotherapy patients: Bridging gaps in preventive care. '

Speaker detailsVerena PetzerSince February 2025, Dr Verena Petzer has been a specialist in internal medicine for hematology and oncology at the Medical University of Innsbruck in Austria.

Read more

Grants & abstract awards

EHA Travel GrantsThe call for travel grant applications closed on March 1, 2025 (23:59 CET). The grants will only be available for investigators with accepted abstracts, submitted during the regular abstract submission.

Read more

EHA Research Conference 2024

Dates: March 18-21, 2024
Location: Borovets, Bulgaria
Chairs: Anna Kabanova, Martina Muckenthaler, Andreas Trumpp, Simon Haas, Jean-Emmanuel Sarry, Achille Iolascon, Britta Will and Brian Huntly

Registration is closed

EHA is proud to announce the second edition of the EHA Research Conference, titled "Molecular vulnerabilities and…

Read more

Target audience

You are a hematologist working at an academic center or a large community hospital that is known for running clinical trials.

Read more

Is CRTH for me?

Eligibility
Applicant must be a trainee or junior faculty and hold an MD or MD/PhD 
Applicant must be actively employed in a hematology or hematology-related research environment 
The applicant must be an EHA member or EHA Guest at the time of application submission…

Read more

Young EHA Committee call for interest

The mission of the Young EHA Committee is to:

Represent the voice of young and early career hematologists and scientists within EHA
Engage these junior members in EHA and EHA-related events
Foster the Young EHA community within the field of hematology
This year, we…

Read more

Does the patient with myelofibrosis feel better through Pacritinib?

Pacritinib is an oral next-generation multikinase inhibitor with specificity for JAK2 and FLT3 being evaluated to treat myelofibrosis in two Phase 3 trials.

Read more